| Morusignin-L(Morusignin-L,2’,4’,5-trihydroxy-3-(γ,γ,γ-hydroxy-dimethyl)propyl-2’’,2"-dimethylpyrano-5",6":6,7-flavonoids),a HIV-1 5’-LTR sequence(HIV-1 reverse transcriptase promoter)inhibitor,was separated from Morus a Lba L.We implemented the total synthesis of this compound.At the same time,the ske Leton was studied for anti-tumor activity,found that it a Lso has significant anti-cancer activity in vitro.My task is to synthesize a series of derivatives that possess the skeleton of Morusignin-L and the skeleton of Oxoindole,and carries on the research of anti-tumor activity.In this topic,24 derivatives were sysnthesized.The structures were characterized by 1HNMR,13CNMR and HR-ESI-MS.The in vitro anti-tumor activities of derivatives against human leukemia cells(K562),human prostatic cancer cells(PC-3)and human lung cancer cells(A549)were inverstigated by MTT method.The IC50of DDP for K562,PC-3and A549 were 27.93μmo L/L,25.77μmol/L,29.85μmol/L,respectively.The results showed that the anti-tumor effect of 23derivatives for K562 are same as DDP,5 derivatives have a good activity to PC-3,to A549 have no obvious inhibitory activity. |